View Zepp Health Corp. Sponsored ADR Class A ZEPP stock quote prices, financial information, real-time forecasts, and company news from CNN.

Zepp is a newcomer to the smartwatch game, but its parent company, Huami, has been producing them under the Amazfit banner for years. While Amazfit has largely focused on budget-minded offerings, Zepp ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Practice may or may not make perfect, but technology might be able to substitute for talent. That is, if Zepp has anything to do with it. The digital sports training device maker has introduced a new ...

The Zepp E is another smartwatch out of the Huami stable that proves this is a company that's getting a lot of things right. The hardware is solid, particularly that gorgeous display. However, we feel ...

Zepp, which entered the North American exercise market 10 years ago with its wearable sensor devices to help people monitor and analyze their exercise data, underwent a relaunch in August. Zepp's ...

Read about the latest sports tech news, innovations, ideas and products that impact players, fans and the sports industry overall at SportTechie.com. They say practice makes perfect, right? Every ...

The Amazfit app is now called Zepp. The app will offer more content in the future. It will also link to other health-related hardware and services going forward. Amazfit is rebranding the app that ...

The Mi Fit app was integral to Xiaomi’s fitness tracker experience. The app has since morphed into Zepp Life and now supports more devices, boasts a sleek UI, and a surprisingly rich experience. If ...

Despite the widespread prevalence of disabling age-related hearing loss, industry surveys and epidemiological studies have consistently documented that only 15% to 30% of adults with mild-to-moderate ...